Engineering Papers⌕ Search

Engineering topics

Jerden, J.

Publications and source records attributed to Jerden, J..

Irradiation of 20L LEU Uranyl Sulfate Solution for Production of Mo-99

Argonne National Laboratory, with support from the National Nuclear Security Administration’s Office of Material Management and Minimization, is assisting SHINE Medical Technologies in the development of accelerator-driven production of 99 Mo using low-enriched uranium (LEU). Technetium-99m ( 99m Tc), a daughter of 99 Mo, is a workhorse of nuclear medicine, used in approximately 40,000 medical testing procedures each day just in the U.S.

07 ISOTOPE AND RADIATION SOURCES↗

Evaluation of Spent Fuel Disposition in Crystalline Rocks: FY18 Progress Report

The U.S. Department of Energy Office of Spent Fuel Waste Disposition (SFWD) established in fiscal year 2010 (FY10) the Spent Fuel Waste Science & Technology (SFWST) Program (formerly the Used Fuel Disposition Campaign - UFDC) program to conduct the research and development (R&D) activities related to storage, transportation and disposal of used nuclear fuel and high level nuclear waste. The Mission of the SFWST is: To identify alternatives and conduct scientific research and technology development to enable storage, transportation and disposal of used nuclear fuel and wastes generated by existing and future nuclear fuel cycles. The work package of Crystalline Disposal R&D directly supports the following SFWST objectives: Develop a fundamental understanding of disposal system performance in a range of environments for potential wastes that could arise from future nuclear fuel cycle alternatives through theory, simulation, testing, and experimentation. ; Develop a computational modeling capability for the performance of storage and disposal options for a range of fuel cycle alternatives, evolving from generic models to more robust models of performance assessment. The objective of the Crystalline Disposal R&D control account is to advance our understanding of long-term disposal of used fuel in crystalline rocks and to develop necessary experimental and computational capabilities to evaluate various disposal concepts in such media. Significant progress has been made in FY18 in both experimental and modeling arenas in evaluation of used fuel disposal in crystalline rocks, especially in model demonstration using field data. The work covers a wide range of research topics identified in the R&D plan. The major accomplishments are summarized.

11 NUCLEAR FUEL CYCLE AND FUEL MATERIALS↗

Evaluation of Spent Fuel Disposition Crystalline Rocks (FY17 Progress Report)

The objective of the Crystalline Disposal R&D control account is to advance our understanding of long-term disposal of used fuel in crystalline rocks and to develop necessary experimental and computational capabilities to evaluate various disposal concepts in such media.

12 MANAGEMENT OF RADIOACTIVE AND NON-RADIOACTIVE W↗

Production of Medical Isotopes with Electron Linacs

Radioisotopes play important roles in numerous areas ranging from medical treatments to national security and basic research. Radionuclide production technology for medical applications has been pursued since the early 1900s both commercially and in nuclear science centers. Many medical isotopes are now in routine production and are used in day-to-day medical procedures. Despite these advancements, research is accelerating around the world to improve the existing production methodologies as well as to develop novel radionuclides for new medical appli-cations. Electron linear accelerators (linacs) represent a unique method for the production of radioisotopes. Even though the basic technology has been around for decades, only recently have electron linacs capable of producing photons with sufficient energy and flux for radioisotope production become available. Housed in Argonne Nation-al Laboratory’s Low Energy Accelerator Facility (LEAF) is a newly upgraded 55 MeV/25-kW electron linear ac-celerator, capable of producing a wide range of radioiso-topes. This talk will focus on the work being performed for the production of the medical isotopes 99Mo (99Mo/99mTc generator), 67Cu, and 47Sc.

Cu-67↗

Speciation and Concentrations of Metals in a Homogeneous Reactor Fuel Solution

Argonne National Laboratory scientists and engineers are collaborating with personnel from Babcock and Wilcox (B&W) to help optimize the design of their Medical Isotope Production System (MIPS). The major components of the MIPS are a homogeneous solution reactor containing low-enriched uranyl nitrate fuel, a molybdenum extraction system consisting of anion exchange columns, and an off-gas treatment facility. The MIPS project is of high priority because it would provide an industrial-scale domestic source of medical isotopes that is not currently available.

Jerden, J.↗

Sorbent Selection Progress Report

This report describes batch studies comparing the uptake of 99 Mo from uranium solutions, chemical and radiolytic stability, and sorbent physical properties. The uranyl nitrate concentration being considered for AHR operation is 150 g-U/L at a pH 1.

11 NUCLEAR FUEL CYCLE AND FUEL MATERIALS↗